These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Mucosal injury of aclacinomycin A in patients with adult acute leukemia--comparison of BH-AC. AMP therapy and BH-AC. DMP therapy]. Takeyama H, Kataoka T, Yano K, Fukutani H, Watanabe E. Rinsho Ketsueki; 1986 Apr; 27(4):508-13. PubMed ID: 3461186 [No Abstract] [Full Text] [Related]
3. [Gastrointestinal symptoms of aclacinomycin A in patients with adult acute nonlymphocytic leukemia--comparison of BH-AC-DMP therapy and BH-AC-AMP therapy]. Kawano F, Tajima H, Matsuoka Y, Asou N, Takatsuki K. Rinsho Ketsueki; 1985 Apr; 26(4):494-8. PubMed ID: 3862889 [No Abstract] [Full Text] [Related]
5. [Combination chemotherapy of N(4)-behenoyl-1-beta-arabinofuranosylcytosine, aclarubicin, 6-MP, and prednisolone (BH-AC. AMP therapy) for adult acute non-lymphocytic leukemia]. Ishige K, Takagi T, Oguro M. Gan To Kagaku Ryoho; 1984 Jul; 11(7):1475-9. PubMed ID: 6588925 [Abstract] [Full Text] [Related]
6. [Treatment of refractory acute lymphocytic leukemia in childhood with BH-AC, ACM, 6-MP, and prednisolone]. Karube T, Maehara M, Ijima H, Muchi H. Rinsho Ketsueki; 1984 May; 25(5):613-8. PubMed ID: 6590894 [No Abstract] [Full Text] [Related]
7. Nationwide randomized comparative study of daunorubicin and aclarubicin in combination with behenoyl cytosine arabinoside, 6-mercaptopurine, and prednisolone for previously untreated acute myeloid leukemia. Nagura E, Kimura K, Yamada K, Ohta K, Maekawa T, Takaku F, Uchino H, Masaoka T, Amaki I, Kawashima K. Cancer Chemother Pharmacol; 1994 May; 34(1):23-9. PubMed ID: 8174198 [Abstract] [Full Text] [Related]
8. [Treatment of acute non-lymphocytic leukemia with concurrent administration of N4-behenoyl-beta-D-arabinofuranosylcytosine, aclacinomycin A, 6-mercaptopurine and prednisolone; a pilot study (author's transl)]. Hirano M, Morishita Y, Ino T, Matsui T, Shimizu S, Shigemura H, Nakamura K, Ono Y, Saito M. Rinsho Ketsueki; 1981 Mar; 22(3):299-305. PubMed ID: 6944508 [No Abstract] [Full Text] [Related]
10. [Treatment of acute myelogenous leukemia with concurrent administration of N4-behenoyl-ara-C, aclacinomycin A, 6-mercaptopurine and prednisolone]. Ino T, Saito M, Matsui T, Shimizu S, Shigemura H, Nakamura K, Ono Y, Okamoto M, Takada T, Imura H. Rinsho Ketsueki; 1985 Feb; 26(2):139-46. PubMed ID: 3860668 [No Abstract] [Full Text] [Related]
13. [Urotoxicity of enocitabine (BH-AC) and aclarubicin (ACM) in pediatric patients with hematological malignancies]. Fujiwara F, Yoshihara T, Ikushima S, Esumi N, Todo S, Morioka Y, Imashuku S, Okano S, Hashida T, Ishii T. Rinsho Ketsueki; 1988 Sep; 29(9):1388-93. PubMed ID: 3063854 [No Abstract] [Full Text] [Related]
14. Behenoyl cytosine arabinoside, aclacinomycin A, 6-mercaptopurine, and prednisolone combination therapy for acute non-lymphocytic leukaemia in adults. Yoshida M, Suda K, Tsuboyama A, Sasaki R, Kitagawa S, Kano Y, Muto Y, Takaku F, Sakamoto S, Miura Y. Eur J Haematol; 1989 Jul; 43(1):1-6. PubMed ID: 2767238 [Abstract] [Full Text] [Related]
18. [Adriamycin-aclacinomycin therapy (AA therapy) for acute leukemia unresponsive to BH-AC-DMP therapy]. Kobayashi M, Tahara T. Gan To Kagaku Ryoho; 1983 Jun; 10(6):1473-9. PubMed ID: 6575727 [Abstract] [Full Text] [Related]
19. [Results of follow-up studies on prognosis after immunotherapy with bestatin in acute nonlymphocytic leukemia]. Ota K, Kurita S, Yamada K, Masaoka T, Uzuka Y, Ogawa N. Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1017-25. PubMed ID: 3963846 [Abstract] [Full Text] [Related]
20. Daunorubicin versus aclarubicin in combination with cytarabine and thioguanine in elderly patients with acute nonlymphocytic leukemia, a preliminary report. Björkholm M, Killander A. Eur J Haematol Suppl; 1987 Apr; 47():49-54. PubMed ID: 3471525 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]